Allergan, the Irish-owned pharmaceutical company who create Botox, opened a new €160 million facility in Westport to meet global demand.

Ever since the invention of Botulinum toxin, or Botox as its more commonly known, in the 1980s, women and men all around the world have been obsessed with the injectable in a bid to derail the aging process.

Allergan plc, the Irish-headquartered, New York-listed company who is responsible for manufacturing the global supply of the substance, opened a new €160m facility at its Westport campus in Co Mayo. 

Allergan plc was formed in February 2015 when Irish–registered Actavis plc acquired US–registered Allergan, Inc., and assumed the Allergan name.

The Biologics 2 facility will create 63 jobs in the area and takes the company’s overall investment in Ireland since it began operations to more than €750 million. It will also enhance Ireland’s position as a strategic global hub.

“Our new biologics facility will allow us to meet continued global demand for Allergan’s flagship products”

The new building will increase Allergan’s capacity to make Botox and meet global demand, which generates annual sales of more than €3 billion – by far the company’s top-selling product. Allergan recently shipped its 100 millionth vial of Botox.

A 2015 study from the American Society of Plastic Surgeons said that the number of men getting injections increased by 337 percent since 2000.

Biologics 2 also includes a state-of-the-art microbiology and cell-based laboratory, and research and development facilities to support the company’s strategic expansion through advances in discovery, development and manufacturing.

“This announcement is further evidence of how the West can provide a wonderful environment for investors and employers”

Employing more than 18,000 people around the world, one in ten employees in Allergan’s workforce are now based in Ireland.

Paul Coffey, vice president of global manufacturing and site lead at Allergan Westport, said; “This €160m investment underpins Allergans commitment to advancement in the biologics arena and we are delighted that Ireland is home to this strategic expansion.

“Our new biologics facility, added to our existing biologics facility, will allow us to meet continued global demand for Allergan’s flagship products.”

The launch of the new building was officiated by Minister Michael Ring, Minister for Rural and Community Development. Speaking at the opening, Minister Ring said, “Allergan’s further expansion is a vote of confidence in Mayo and the West. Allergan is a fantastic employer and it’s great to see it further cement its presence here in Westport. Speaking as someone from Westport, Allergan has had a remarkably positive impact on the town and on the region.

“This announcement is further evidence of how the West can provide a wonderful environment for investors and employers. I commend Allergan for putting their trust in the West of Ireland,” he added.

The company originally started out with 25 employees in 1977 and has four locations across Ireland; two in Dublin, one in Mayo and one in Galway and contributed €308m to Ireland’s GDP last year.

By Stephen Larkin

Published: 30 January, 2020

Recommended